Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GNPS-Urine-viborg

ABSTRACT: sqdqfqfqwdfg

INSTRUMENT(S): maXis

ORGANISM(S): Mus <mouse, Genus> (ncbitaxon:10088)

SUBMITTER: Djawed Bennouna

PROVIDER: MSV000081655 | GNPS | Tue Oct 31 05:25:00 GMT 2017

REPOSITORIES: GNPS

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Quick-start infrastructure for untargeted metabolomics analysis in GNPS.

Project description: Not available

| S-EPMC8705952 | biostudies-literature

Feature-based molecular networking in the GNPS analysis environment.

Project description: Not available

| S-EPMC7885687 | biostudies-literature

Characterization of Wood and Graphene Nanoplatelets (GNPs) Reinforced Polymer Composites.

Project description: Not available

| S-EPMC7254240 | biostudies-literature

Optimization of the Electrochemical Method of Obtaining Graphene Nanoplatelets (GNPs).

Project description: Not available

| S-EPMC10057930 | biostudies-literature

Comparison between Nestin+ and Nestin- Ptch1 deficient GNPs

Project description:The intermediate filament protein Nestin serves as a biomarker for stem cells and has been used to identify subsets of cancer stem-like cells. However, the mechanistic contributions of Nestin to cancer pathogenesis are not understood. Here we report that Nestin binds the hedgehog pathway transcription factor Gli3 to mediate the development of medulloblastomas of the hedgehog subtype. In a mouse model system, Nestin levels increased progressively during medulloblastoma formation resulting in enhanced tumor growth. Conversely, loss of Nestin dramatically inhibited proliferation and promoted differentiation. Mechanistic investigations revealed that the tumor-promoting effects of Nestin were mediated by binding to Gli3, a zinc finger transcription factor that negatively regulates hedgehog signaling. Nestin binding to Gli3 blocked Gli3 phosphorylation and its subsequent proteolytic processing, thereby abrogating its ability to negatively regulate the hedgehog pathway. Our findings show how Nestin drives hedgehog pathway-driven cancers and uncover in Gli3 a therapeutic target to treat these malignancies.

2016-08-09 | GSE84392 | GEO

Voltammetric analysis of pholcodine on graphene-modified GNPs/PTs with green assessment.

Project description: Not available

| S-EPMC10919016 | biostudies-literature

GNPS Dashboard: collaborative exploration of mass spectrometry data in the web browser.

Project description: Not available

| S-EPMC8831450 | biostudies-literature

Metabolomics analysis revealed the effects of different treatments on the metabolic profile of HaCaT cells

Project description:To investigate the regulatory effects of the ECM@SF-AGS-CS-LA hydrogel (HC), exosomes (HB), and their combination (HA) on the metabolic profiles of wound tissues in diabetic mice, HaCaT keratinocytes were employed as an in vitro cellular model. Untargeted metabolomics profiling was performed on HaCaT cells subjected to the respective treatments. Five pairwise comparisons were conducted: HC versus HD (diabetic control), HB versus HD, HA versus HD, HA versus HC, and HA versus HB. KEGG pathway enrichment analysis was applied to identify biologically relevant pathways significantly associated with differentially abundant metabolites (P < 0.05). This analysis revealed 8, 28, 30, 30, and 97 significantly enriched pathways in the HC vs HD, HB vs HD, HA vs HD, HA vs HC, and HA vs HB comparisons, respectively.

2026-05-14 | MTBLS14481 | MetaboLights

Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington’s disease subjects

Project description:Huntington's disease (HD) is a severe neurological disease leading to psychiatric symptoms, motor impairment and cognitive decline. The disease is caused by a CAG expansion in the huntingtin (HTT) gene, but how this translates into the clinical phenotype of HD remains elusive. Using liquid chromatography mass spectrometry, we analyzed the metabolome of cerebrospinal fluid (CSF) from premanifest and manifest HD subjects as well as control subjects. Inter-group differences revealed that the tyrosine metabolism, including tyrosine, thyroxine, L-DOPA and dopamine, was significantly altered in manifest compared with premanifest HD. These metabolites demonstrated moderate to strong associations to measures of disease severity and symptoms. Thyroxine and dopamine also correlated with the five year risk of onset in premanifest HD subjects. The phenylalanine and the purine metabolisms were also significantly altered, but associated less to disease severity. Decreased levels of lumichrome were commonly found in mutated HTT carriers and the levels correlated with the five year risk of disease onset in premanifest carriers. These biochemical findings demonstrates that the CSF metabolome can be used to characterize molecular pathogenesis occurring in HD, which may be essential for future development of novel HD therapies.

2019-06-21 | MTBLS749 | MetaboLights

Comparison between Nestin+ and Nestin- Ptch1 deficient GNPs

2016-08-09 | E-GEOD-84392 | biostudies-arrayexpress